Abstract
Renal osteodystrophy (ROD) is a severe problem in end-stage renal disease (3). ROD usually consists of a combination of osteomalacia, caused by a decrease of circulating 1,25-dihydroxyvitamin D3, and osteofibrosis, caused by the secondary hyperparathyroidism. The common failure is the deficiency of calcitriol [1,25(OH)2- D3] in the course of chronic renal failure. It has been reported in previous studies that treatment with calcitriol and/or alpha-calcidol increase bone mineral density [BMD] (5,6).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kanis, J.A., Devogelaer, J.P., Gennari, C.:Practical guide for the use of bone mineral measurements in the assessment of treatment of osteoporosis: a position paper of the European foundation for osteoporosis and bone disease. Osteoporosis Int. 1996; 6: 256–261
Kalender, W.A.:Physik und Methodik der Knochenmineraldichtemessung.In: Schild, H.H., Heller, M. (Hrsg.): Osteoporose.Thieme Verlag Stuttgart, New York (1992) 78–99
Llach, F.:Renal osteodystrophy.In: Jacobs, C., Kjellstrand, C.M., Koch, K.M., Winchester, J.F. (eds.):Replacement of renal function by dialysis.Kluwer Academic Publishers, Dordrecht, Boston, London (1996) 1160–1235
Przedlacki, J., Manelius, J., Huttunen, K.:Bone mineral density evaluated by dual-energy X-ray absorptiometry after one-year treatment with calcitriol started in the predialysis phase of chronic renal failure.Nephron 1995; 69: 433–437
Ross, P.D., Genant, H.K., Davis, J.W., Miller, P.D., Wasnich, R.D.:Predicting vertebral fracture incidence from prevalent fractures and bone density among non black, osteoporotic women.Osteoporosis Int. 1993; 3: 120–126
Ruedin, P., Rizzoli, R., Slosman, D., Leski, M., Bonjour, J.P.:Effects of oral calcitriol on bone mineral density in patients with end-stage renal failure. Kidney Int. 1994; 245–252
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media New York
About this chapter
Cite this chapter
Krause, R. et al. (1999). Exposure to a Suberythemal Dose of Ultraviolet Irradiation Prevents Bone Loss in Hemodialysis Patients. In: Holick, M.F., Jung, E.G. (eds) Biologic Effects of Light 1998. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-5051-8_22
Download citation
DOI: https://doi.org/10.1007/978-1-4615-5051-8_22
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7296-7
Online ISBN: 978-1-4615-5051-8
eBook Packages: Springer Book Archive